Candesartan augments compensatory changes in medullary transport proteins in the diabetic rat kidney

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 6, 2008, Pages

  Blount, Mitsi A ^a   Sands, Jeff M ^a   Kent, Kimilia J ^a   Smith, Tekla D ^a   Price, S Russ ^a   Klein, Janet D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; AQP2; Aquaporin; NKCC2; UT A urea transporter

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AQUAPORIN 2; CANDESARTAN; CARRIER PROTEIN; PROTEIN NKCC2; PROTEIN UT A1; PROTEIN UT A3; UNCLASSIFIED DRUG; ANGIOTENSIN RECEPTOR ANTAGONIST; AQP2 PROTEIN, RAT; BENZIMIDAZOLE DERIVATIVE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2 PROTEIN; SODIUM-POTASSIUM CHLORIDE COTRANSPORTER 2 PROTEIN; TETRAZOLE DERIVATIVE; UREA TRANSPORTER; UT A1 PROTEIN, RAT; UT-A1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INHIBITION; MALE; NONHUMAN; OSMOTIC DIURESIS; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINALYSIS; ANIMAL; DIABETIC NEPHROPATHY; DRUG EFFECT; ELECTROLYTE BALANCE; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; KIDNEY CONCENTRATING CAPACITY; KIDNEY MEDULLA; METABOLISM; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AQUAPORIN 2; BENZIMIDAZOLES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPERGLYCEMIA; KIDNEY CONCENTRATING ABILITY; KIDNEY MEDULLA; MALE; MEMBRANE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; TETRAZOLES; WATER-ELECTROLYTE BALANCE;

EID: 48249126235     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00600.2007     Document Type: Article

References (14)

1. Blount MA, Klein JD, Martin CF, Tchapyjnikov D, Sands JM. Forskolin stimulates phosphorylation and membrane accumulation of UT-A3. Am J Physiol Renal Physiol 293: F1308-F1313, 2007.
2. Kasanuki H, Hagiwara N, Kawana M, Sumiyoshi T, Honda T, Haze K, Takagi A, Yamaguchi J, Nagashima M, Koyanagi R, Yamauchi T, Origasa H, Ogawa H. Late-Breaking Clinical Trial Abstracts From the American Heart Association's Scientific Sessions 2007. Circulation 116: 2627-2633, 2007.
3. Kim D, Sands JM, Klein JD. Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats. Am J Physiol Renal Physiol 285: F303-F309, 2003.
4. Kim D, Sands JM, Klein JD. Role of vasopressin in diabetes mellitus-induced changes in medullary transport proteins involved in urine concentration in Brattleboro rats. Am J Physiol Renal Physiol 286: F760-F766, 2004.
5. Klein JD, Le Quach D, Cole JM, Disher K, Mongiu AK, Wang X, Bernstein KE, Sands JM. Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins. Am J Physiol Renal Physiol 283: F517-F524, 2002.
6. Klein JD, Price SR, Bailey JL, Jacobs JD, Sands JM. Glucocorticoids mediate a decrease in AVP-regulated urea transporter in diabetic rat inner medulla. Am J Physiol Renal Physiol 273: F949-F953, 1997.
7. Nielsen S, Terris J, Smith CP, Hediger MA, Ecelbarger CA, Knepper MA. Cellular and subcellular localization of the vasopressin-regulated urea transporter in rat kidney. Proc Natl Acad Sci USA 93: 5495-5500, 1996.
8. Pech V, Klein JD, Kozlowski SD, Wall SM, Sands JM. Vasopressin increases urea permeability in the initial IMCD from diabetic rats. Am J Physiol Renal Physiol 289: F531-F535, 2005.
9. Rossing K, Christensen PK, Hansen BV, Carstensen B, Parving HH. Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study. Diabetes Care 26: 150-155, 2003.
10. Sands JM, Layton HE. The urine concentrating mechanism and urea transporters. In: The Kidney: Physiology and Pathophysiology (4th ed.), edited by Alpern RJ and SC H. San Diego: Elsevier, 2008, p. 1143-1178.
11. Shayakul C, Knepper MA, Smith CP, DiGiovanni SR, Hediger MA. Segmental localization of urea transporter mRNAs in rat kidney. Am J Physiol Renal Physiol 272: F654-F660, 1997.
12. Snedecor GW, Cochran WG. Statistical Methods. Ames, IA: Iowa State Univ. Press, 1980.
13. Stewart GS, Fenton RA, Wang W, Kwon TH, White SJ, Collins VM, Cooper G, Nielsen S, Smith CP. The basolateral expression of mUT-A3 in the mouse kidney. Am J Physiol Renal Physiol 286: F979-F987, 2004.
14. Wang XY, Beutler K, Nielsen J, Nielsen S, Knepper MA, Masilamani S. Decreased abundance of collecting duct urea transporters UT-A1 and UT-A3 with ECF volume expansion. Am J Physiol Renal Physiol 282: F577-F584, 2002.